Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab

Joseph Kahwaji, Stanley C. Jordan, Reiad Najjar, Patarapha Wongsaroj, Jua Choi, Alice Peng, Rafael Villicana, Ashley Vo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1276-1285
Number of pages10
JournalTransplant International
Volume29
Issue number12
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

ASJC Scopus Subject Areas

  • Transplantation

Keywords

  • ABMR
  • desensitization
  • donor-specific antibodies
  • plasma exchange
  • transplant glomerulopathy
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Male
  • Living Donors
  • Immunosuppression Therapy
  • Kidney Transplantation/methods
  • Transplant Recipients
  • Immunoglobulins, Intravenous/therapeutic use
  • Kidney Failure, Chronic/mortality
  • Adult
  • Female
  • Retrospective Studies
  • Glomerular Filtration Rate
  • Histocompatibility Testing
  • Risk Factors
  • Graft Survival
  • Treatment Outcome
  • Graft Rejection
  • Immunosuppressive Agents/therapeutic use
  • Rituximab/therapeutic use
  • HLA Antigens/immunology
  • Proteinuria/immunology
  • Desensitization, Immunologic

Cite this